The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver

Journal of Molecular Medicine

Volumn 93, Issue 8, 2015, Pages 867-878

  Arshad, Muhammad Imran ^a,b,c,d   Piquet Pellorce, Claire ^a,b,c   Filliol, Aveline ^a,b,c   L’Helgoualc’h, Annie ^a,b,c   Lucas Clerc, Catherine ^b   Jouan Lanhouet, Sandrine ^a,b,c,e   Dimanche Boitrel, Marie Thérèse ^a,b,c   Samson, Michel ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d UNIVERSITY OF AGRICULTURE   (Pakistan)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Acute hepatitis; Cytokine; Fibroblasts; IL 33; PARP 1; RIP kinase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; INTERLEUKIN 33; LIVER PROTECTIVE AGENT; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NECROSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLYINOSINIC POLYCYTIDYLIC ACID; STAUROSPORINE; UNCLASSIFIED DRUG; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; N-(OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)-N,N-DIMETHYLACETAMIDE HYDROCHLORIDE; NECROSTATIN-1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHENANTHRENE DERIVATIVE;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LIVER CELL; LIVER INJURY; MOUSE; NECROPTOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STELLATE CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENETICS; HEPATITIS; INJURIES; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; CELL DEATH; CELLS, CULTURED; DOWN-REGULATION; HEPATITIS; HEPATOCYTES; HUMANS; IMIDAZOLES; INDOLES; INTERLEUKIN-33; LIVER; MICE, INBRED C57BL; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS;

EID: 84937967401     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1270-6     Document Type: Article

References (61)

1. Malhi H, Guicciardi ME, Gores GJ (2010) Hepatocyte death: a clear and present danger. Physiol Rev 90:1165–1194
2. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700–714
3. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123
4. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137:1100–1111
5. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC et al (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science (New York, NY) 325:332–336
6. Jurisic V, Srdic-Rajic T, Konjevic G, Bogdanovic G, Colic M (2011) TNF-alpha induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. The Journal of membrane biology 239:115–122
7. Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, Rachmilewitz J et al (2009) Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 50:198–206
8. Csak T, Dolganiuc A, Kodys K, Nath B, Petrasek J, Bala S et al (2011) Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice. Hepatology 53:1917–1931
9. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90:196–203
10. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K (2000) Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 97:5498–5503
11. Zheng SJ, Wang P, Tsabary G, Chen YH (2004) Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 113:58–64
12. Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, Okumura K et al (2008) Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A 105:10895–10900
13. Beraza N, Malato Y, Sander LE, Al-Masaoudi M, Freimuth J, Riethmacher D et al (2009) Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage. J Exp Med 206:1727–1737
14. Ni HM, Chen X, Ding WX, Schuchmann M, Yin XM (2008) Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 173:962–972
15. Kunstle G, Hentze H, Germann PG, Tiegs G, Meergans T, Wendel A (1999) Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology 30:1241–1251
16. Liedtke C, Bangen JM, Freimuth J, Beraza N, Lambertz D, Cubero FJ et al (2011) Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 141:2176–2187
17. Zhou Y, Dai W, Lin C, Wang F, He L, Shen M et al (2013) Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediat Inflamm 2013:706156
18. Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Le Moigne-Muller G, Van Herreweghe F et al (2012) TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 19:2003–2014
19. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732–738
20. Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1–20
21. Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136
22. Marvie P, Lisbonne M, L’Helgoualc’h A, Rauch M, Turlin B, Preisser L et al (2010) Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 14:1726–1739
23. Arshad MI, Piquet-Pellorce C, Samson M (2012) IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver Int 32:1200–1210
24. Arshad MI, Rauch M, L’Helgoualc’h A, Julia V, Leite-de-Moraes MC, Lucas-Clerc C et al (2011) NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 41:2341–2348
25. Arshad MI, Patrat-Delon S, Piquet-Pellorce C, L’Helgoualc’h A, Rauch M, Genet V et al (2013) Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis. PLoS One 8:e74278
26. Sakai N, Van Sweringen HL, Quillin RC, Schuster R, Blanchard J, Burns JM et al (2012) Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology 56:1468–1478
27. Arshad MI, Piquet-Pellorce C, L’Helgoualc’h A, Rauch M, Patrat-Delon S, Ezan F et al (2012) Tumor necrosis factor related apoptosis inducing ligand (TRAIL), but not FasL and tumor necrosis factor alpha (TNFa), regulates interleukin (IL)-33 expression in murine hepatocytes during acute hepatitis. Hepatology 56:2353–2362
28. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104:282–287
29. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A 104:18660–18665
30. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S et al (2012) Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 56:26–33
31. Lamkanfi M, Dixit VM (2009) IL-33 raises alarm. Immunity 31:5–7
32. Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106:9021–9026
33. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84–98
34. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G (2009) Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 284:19420–19426
35. Ali S, Nguyen DQ, Falk W, Martin MU (2010) Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem Biophys Res Commun 391:1512–1516
36. Bourd-Boittin K, Basset L, Bonnier D, L’Helgoualc’h A, Samson M, Theret N (2009) CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J Cell Mol Med 13:1526–1535
37. Lisbonne M, L’Helgoualc’h A, Nauwelaers G, Turlin B, Lucas C, Herbelin A et al (2011) Invariant natural killer T-cell-deficient mice display increased CCl(4)-induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration. Eur J Immunol 41:1720–1732
38. Diana J, Beaudoin L, Gautron AS, Lehuen A (2011) NKT and tolerance. Methods Mol Biol 677:193–206
39. Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, Srinivas P et al (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 108:15312–15317
40. Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T et al (2011) RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35:908–918
41. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112–119
42. Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M et al (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477:330–334
43. Gunther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H et al (2011) Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477:335–339
44. An J, Mehrhof F, Harms C, Lattig-Tunnemann G, Lee SL, Endres M et al (2013) ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis. J Hepatol 58:297–305
45. Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S et al (2014) Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS open bio 4:777–787
46. Zhang YF, He W, Zhang C, Liu XJ, Lu Y, Wang H et al (2014) Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 225:445–453
47. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124:601–613
48. Kaufmann T, Jost PJ, Pellegrini M, Puthalakath H, Gugasyan R, Gerondakis S et al (2009) Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30:56–66
49. Han J, Zhong CQ, Zhang DW (2011) Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12:1143–1149
50. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G (1995) Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190–198
51. Kusters S, Gantner F, Kunstle G, Tiegs G (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111:462–471
52. Galluzzi L, Kroemer G (2011) Necroptosis turns TNF lethal. Immunity 35:849–851
53. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL et al (2012) Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol 18:119–125
54. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (New York, NY) 274:1379–1383
55. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z et al (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106:4402–4407
56. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H et al (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830–1838
57. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J et al (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. doi:10.1002/hep.25873
58. Lee TH, Shank J, Cusson N, Kelliher MA (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 279:33185–33191
59. Degterev A, Hitomi J, Germscheid M, Ch’en IL, Korkina O, Teng X et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313–321
60. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G (1995) Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 22:226–229
61. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER (2010) Neutrophil kinetics in health and disease. Trends Immunol 31:318–324